HK1038591A1 - 聚(adp-核糖)聚合酶基因 - Google Patents

聚(adp-核糖)聚合酶基因

Info

Publication number
HK1038591A1
HK1038591A1 HK02100014.0A HK02100014A HK1038591A1 HK 1038591 A1 HK1038591 A1 HK 1038591A1 HK 02100014 A HK02100014 A HK 02100014A HK 1038591 A1 HK1038591 A1 HK 1038591A1
Authority
HK
Hong Kong
Prior art keywords
adp
ribose
poly
polymerase gene
polymerase
Prior art date
Application number
HK02100014.0A
Other languages
English (en)
Inventor
M‧科克
T‧赫格爾
B‧克雷格爾
B‧奧特爾巴赫
W‧盧比施
H‧-G‧勒麥雷
Original Assignee
Basf公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf公司 filed Critical Basf公司
Publication of HK1038591A1 publication Critical patent/HK1038591A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1077—Pentosyltransferases (2.4.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/02—Pentosyltransferases (2.4.2)
    • C12Y204/0203—NAD+ ADP-ribosyltransferase (2.4.2.30), i.e. tankyrase or poly(ADP-ribose) polymerase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91091—Glycosyltransferases (2.4)
    • G01N2333/91142—Pentosyltransferases (2.4.2)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK02100014.0A 1998-06-05 2002-01-02 聚(adp-核糖)聚合酶基因 HK1038591A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19825213 1998-06-05
DE19908837 1999-03-01
PCT/EP1999/003889 WO1999064572A2 (de) 1998-06-05 1999-06-04 Poly(adp-ribose) polymerase-gene

Publications (1)

Publication Number Publication Date
HK1038591A1 true HK1038591A1 (zh) 2002-03-22

Family

ID=26046644

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02100014.0A HK1038591A1 (zh) 1998-06-05 2002-01-02 聚(adp-核糖)聚合酶基因

Country Status (24)

Country Link
US (3) US7754459B1 (zh)
EP (1) EP1082416B1 (zh)
JP (1) JP2002517231A (zh)
KR (1) KR20010052582A (zh)
CN (1) CN1304446A (zh)
AR (1) AR020326A1 (zh)
AT (1) ATE358175T1 (zh)
AU (1) AU4605999A (zh)
BG (1) BG105018A (zh)
BR (1) BR9910967A (zh)
CA (1) CA2330206C (zh)
CO (1) CO5070700A1 (zh)
DE (1) DE59914280D1 (zh)
ES (1) ES2285842T3 (zh)
HK (1) HK1038591A1 (zh)
HR (1) HRP20010013A2 (zh)
HU (1) HUP0103190A2 (zh)
ID (1) ID27819A (zh)
IL (1) IL139750A0 (zh)
NO (1) NO20006153L (zh)
PL (1) PL345334A1 (zh)
SK (1) SK17892000A3 (zh)
TR (1) TR200003624T2 (zh)
WO (1) WO1999064572A2 (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19921567A1 (de) 1999-05-11 2000-11-16 Basf Ag Verwendung von Phthalazine-Derivaten
EP1192258A2 (en) 1999-06-16 2002-04-03 Icos Corporation Human poly(adp-ribose) polymerase 2 materials and methods
AU2001240542A1 (en) 2000-02-01 2001-08-14 Basf Aktiengesellschaft Heterocyclic compounds and their use as parp inhibitors
NZ587586A (en) 2005-07-18 2012-04-27 Bipar Sciences Inc Treatment of cancer
CN101522609A (zh) 2006-09-05 2009-09-02 彼帕科学公司 癌症的治疗
WO2008030891A2 (en) 2006-09-05 2008-03-13 Bipar Sciences, Inc. Inhibition of fatty acid synthesis by parp inhibitors and methods of treatment thereof
US7732491B2 (en) 2007-11-12 2010-06-08 Bipar Sciences, Inc. Treatment of breast cancer with a PARP inhibitor alone or in combination with anti-tumor agents
GB201102865D0 (en) 2011-02-18 2011-04-06 Danisco Feed additive composition
GB201102857D0 (en) 2011-02-18 2011-04-06 Danisco Feed additive composition
CA2825365A1 (en) 2011-02-18 2012-08-23 Dupont Nutrition Biosciences Aps Feed additive composition
GB201213801D0 (en) 2012-08-03 2012-09-12 Dupont Nutrition Biosci Aps Feed additive composition
CA3171494A1 (en) 2012-08-29 2014-03-06 Sangamo Biosciences, Inc. Cells genetically modified within the bcl11a gene by a nuclease and various aspects related thereto

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162508A (en) 1987-12-18 1992-11-10 Compagnie Oris Industrie Rare earth cryptates, processes for their preparation, synthesis intermediates and application as fluorescent tracers
US5272057A (en) * 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
FR2707011A1 (en) * 1993-06-25 1994-12-30 Pasteur Sanofi Diagnostics Immunological process for the detection and assay of antibodies directed against poly(ADP-ribose) polymerase, application to diagnosis, kit for its implementation
DE4444949C1 (de) * 1994-12-16 1996-11-21 Deutsches Krebsforsch Vektoren und Viren zur Gentherapie

Also Published As

Publication number Publication date
SK17892000A3 (sk) 2001-09-11
CO5070700A1 (es) 2001-08-28
BG105018A (en) 2001-12-31
KR20010052582A (ko) 2001-06-25
ES2285842T3 (es) 2007-11-16
HUP0103190A2 (hu) 2001-12-28
CA2330206C (en) 2010-04-13
PL345334A1 (en) 2001-12-17
DE59914280D1 (en) 2007-05-10
WO1999064572A2 (de) 1999-12-16
US9051553B2 (en) 2015-06-09
CA2330206A1 (en) 1999-12-16
US20110107444A1 (en) 2011-05-05
WO1999064572A3 (de) 2000-06-08
US7754459B1 (en) 2010-07-13
TR200003624T2 (tr) 2001-06-21
HRP20010013A2 (en) 2001-12-31
EP1082416B1 (de) 2007-03-28
US20160010067A1 (en) 2016-01-14
ID27819A (id) 2001-04-26
NO20006153D0 (no) 2000-12-04
NO20006153L (no) 2001-02-02
IL139750A0 (en) 2002-02-10
JP2002517231A (ja) 2002-06-18
EP1082416A2 (de) 2001-03-14
BR9910967A (pt) 2001-02-13
CN1304446A (zh) 2001-07-18
AU4605999A (en) 1999-12-30
ATE358175T1 (de) 2007-04-15
AR020326A1 (es) 2002-05-08

Similar Documents

Publication Publication Date Title
AU4680599A (en) Thermostable polymerase
HK1039119A1 (en) Dihydropyrimidines.
ZA9811939B (en) Novel macrolides.
PL348333A1 (en) Macrolides
AU3572799A (en) Function-based gene discovery
EP1208234A4 (en) POLY (ETHER-THIOETHER), POLY (ETHERSULFOXIDE) AND POLY (ETHERSULFON) NUCLEIC ACIDS
IL139750A0 (en) Poly (adp-ribose) polymerase gene
HK1049682A1 (en) Endo-beta-N-acetylglucosaminidase gene.
DE69833112D1 (en) Rna polymerase
GB9817704D0 (en) Gene switch
IL146332A0 (en) PrP-LIKE GENE
GB2344591B (en) Thermostable DNA polymerase
EP1038957A4 (en) GENE TSA305
EP1215284A4 (en) TSG TYPE GENE
AU4513599A (en) Nucleotide sequence
EP1080100A4 (en) CYTOSINE DEAMINASE GENE
EP1092021A4 (en) NPY-Y7 RECEPTOR GENE
GB9904573D0 (en) Typewriter
AU2002300127A1 (en) Poly ADP-ribose Polymerase Gene and its Uses
GB9809753D0 (en) Gene
GB9818734D0 (en) Gene
GB9817566D0 (en) Gene
GB9818459D0 (en) Polymerase
GB9822216D0 (en) Gene transfer
GB9819721D0 (en) Novel gene